PL408305A1 - Application of C16 (C16-Cer) ceramide as the biomarker in prediction of premature birth - Google Patents
Application of C16 (C16-Cer) ceramide as the biomarker in prediction of premature birthInfo
- Publication number
- PL408305A1 PL408305A1 PL408305A PL40830514A PL408305A1 PL 408305 A1 PL408305 A1 PL 408305A1 PL 408305 A PL408305 A PL 408305A PL 40830514 A PL40830514 A PL 40830514A PL 408305 A1 PL408305 A1 PL 408305A1
- Authority
- PL
- Poland
- Prior art keywords
- cer
- ceramide
- biomarker
- prediction
- application
- Prior art date
Links
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 title abstract 4
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 title abstract 2
- YDNKGFDKKRUKPY-TURZORIXSA-N N-hexadecanoylsphingosine Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC YDNKGFDKKRUKPY-TURZORIXSA-N 0.000 title abstract 2
- 239000000090 biomarker Substances 0.000 title abstract 2
- 229940106189 ceramide Drugs 0.000 title abstract 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 title abstract 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 title abstract 2
- 208000005107 Premature Birth Diseases 0.000 title 1
- 206010036590 Premature baby Diseases 0.000 title 1
- 238000004159 blood analysis Methods 0.000 abstract 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Przedmiotem wynalazku jest zastosowanie ceramidu C16 (C16-Cer) jako biomarkera w predykcji porodu przedwczesnego oparte o analizę we krwi.The present invention relates to the use of ceramide C16 (C16-Cer) as a biomarker in the prediction of preterm delivery based on blood analysis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL408305A PL408305A1 (en) | 2014-05-23 | 2014-05-23 | Application of C16 (C16-Cer) ceramide as the biomarker in prediction of premature birth |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL408305A PL408305A1 (en) | 2014-05-23 | 2014-05-23 | Application of C16 (C16-Cer) ceramide as the biomarker in prediction of premature birth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL408305A1 true PL408305A1 (en) | 2015-12-07 |
Family
ID=54776544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL408305A PL408305A1 (en) | 2014-05-23 | 2014-05-23 | Application of C16 (C16-Cer) ceramide as the biomarker in prediction of premature birth |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL408305A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL423168A1 (en) * | 2017-10-16 | 2019-04-23 | Grzegorz Raba | Application of biochemical markers for diagnosing of premature birth |
-
2014
- 2014-05-23 PL PL408305A patent/PL408305A1/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL423168A1 (en) * | 2017-10-16 | 2019-04-23 | Grzegorz Raba | Application of biochemical markers for diagnosing of premature birth |
| PL237304B1 (en) * | 2017-10-16 | 2021-04-06 | Grzegorz Raba | Application of biochemical markers for diagnosing of premature birth |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201791029A1 (en) | ANTIBODIES AGAINST INTERLEUKIN-33 AND THEIR APPLICATION | |
| EP3424214C0 (en) | PLANETARY SCALE ANALYSIS SYSTEM | |
| DK3656875T3 (en) | Non-invasive prenatal diagnosis | |
| CL2015002562A1 (en) | Anti-b7-h4 antibodies and immunoconjugates | |
| CR20160199A (en) | COMBINED THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST | |
| MX2022015250A (en) | AN ANTI-IL-23A ANTIBODY FOR USE IN THE TREATMENT OF CROHN'S DISEASE. | |
| NZ723858A (en) | Anti-human ox40l antibodies, uses & methods | |
| CR20160270A (en) | ANTI-TAU ANTIBODIES (pS422) HUMANIZED AND USED METHODS | |
| BR112017023872A2 (en) | anti-cd166 antibodies, activatable anti-cd166 antibodies and methods of use | |
| EP4282484A3 (en) | Bispecific antibodies against cd3epsilon and bcma for use in treatment of diseases | |
| EA201791485A1 (en) | ANTI-CD47-ANTIBODIES AND THEIR APPLICATIONS | |
| AR090973A1 (en) | USEFUL ANTIBODIES FOR CANCER DIAGNOSIS | |
| EP3536284C0 (en) | JOINT RECONSTRUCTION DEVICE | |
| EA201691610A8 (en) | ANTI-JAGGED1 ANTIBODIES AND METHODS OF APPLICATION | |
| JO3791B1 (en) | BMP6-targeted antibody compositions and methods | |
| BR112016024494A2 (en) | peptide analogs with branched amino acid probe (s) | |
| EA201690213A1 (en) | COMPOSITIONS AND METHOD FOR TREATMENT OF CONNECTED STATES | |
| MX2017011194A (en) | ANTIBODIES, USES AND METHODS. | |
| WO2016001754A3 (en) | Methods for three dimensional reconstruction and determining the quality of an embryo | |
| DK3169232T3 (en) | INTERMITTING MEASUREMENT OF THE PARTIAL PRESSURE OF AN ANALYT IN SKIN TISSUE | |
| HK1257415A1 (en) | Antibody or antibody fragment or non-ig scaffold binding to a binding region of an anti-n-methyl-d-aspartate (nmda) receptor antibody | |
| DK3149049T3 (en) | IL-22 FOR USE IN THE TREATMENT OF METABOLISM DISEASES | |
| EP3458836C0 (en) | NON-INVASIVE BLOOD ANALYSIS | |
| MX2022010954A (en) | Device for detecting misfolded proteins and methods of use therof. | |
| MX2017006075A (en) | BIOMARKERS FOR THE PROGRESSION OF DISEASES IN MELANOMA. |